Ledger.Open graph →
SEC Form D · filed May 10, 2022

Apnimed, Inc

Offering
$62.5M
Sold
$37.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Joseph C. Avellone · Cambridge, MADirectorDennis C. Molnar · Cambridge, MAExec · DirectorMichael G. Rogers · Cambridge, MAExecChris C. Dimitropoulos · Cambridge, MADirectorIsaac C. Cheng · Cambridge, MADirectorStefan C. Larson · Cambridge, MADirectorBarry G. Wohl · Cambridge, MAExecLawrence G. Miller · Cambridge, MAExec · DirectorEvan Sugden · Salt Lake City, UTExec · DirectorWen-Hui Chen · Camana Bay, Cayman IslandsExecRichard H. Coles · Camana Bay, Cayman IslandsExecChristopher O. Day · Camana Bay, Cayman IslandsDirectorTerence S. Greene · New York, NYDirectorJames C. Galeota · Cambridge, MADirectorMark Hutchinson · Natick, MAExecPeter Gajdos · Natick, MAExec · DirectorRich Hossfeld · Natick, MADirectorTexo Energy, LLC · Dallas, TXDirectorRaffi Garabedian · Natick, MADirectorGabriel Kra · Natick, MAExecDerek Warnick · Natick, MAExec · DirectorRiyaz G. Nooruddin · Grand Cayman, Cayman IslandsDirectorDavid Eaglesham · Natick, MADirectorSusan P. Gordon · Radnor, PADirectorNatalie Mortimer · Salt Lake City, UTDirectorErin Whitelock · Salt Lake City, UTExec · DirectorAdelaide Corey-Disch · Sandy, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗